What is the main purpose of this 8-K filing?

This 8-K filing serves to inform investors about UnitedHealth Group's participation in an upcoming interview at a financial conference, where senior leaders will discuss the company's strategic direction, market standing, recent financial performance, and future outlook.

Where can I access the discussion mentioned in the filing?

A live audio webcast of the interview will be available on the Investor Relations section of UnitedHealth Group's official website, www.unitedhealthgroup.com.

What specific topics are expected to be covered in the interview?

The interview is anticipated to cover UnitedHealth Group's overall strategy, its competitive positions within various markets, recent business results, and the company's expectations for its end markets.

Will the information shared in this interview be considered legally 'filed' with the SEC?

No, the information provided during the interview and webcast, as disclosed in this Item 7.01 of the 8-K, is not considered 'filed' for the purposes of Section 18 of the Securities Exchange Act of 1934, nor is it automatically incorporated by reference into other SEC filings, unless UnitedHealth Group specifically states otherwise in a future filing.

UNH 8-K: Regulation FD — May 30, 2023

Summary

UnitedHealth Group (UNH) has filed an 8-K report to disclose that senior leaders will participate in an interview at Bernstein's 39th Annual Strategic Decisions Conference on June 1, 2023. This interview is expected to cover the company's strategy, market positions, recent performance, and outlook for its various business segments. Investors should pay close attention to this event as it may provide forward-looking insights and commentary beyond standard financial reporting.

Key Highlights

1UNH senior leadership participation in Bernstein's 39th Annual Strategic Decisions Conference.
2Interview scheduled for Thursday, June 1, 2023, at 10:00 a.m. Eastern Time.
3Discussion topics to include company strategy, market positions, recent results, and end-market expectations.
4A live audio webcast will be available via the UNH Investor Relations website.
5The disclosure is for informational purposes under Regulation FD.
6Information presented is not considered 'filed' for Section 18 or incorporated by reference into other filings unless expressly stated.

UNITEDHEALTH GROUP INC 8-K Report, Regulation FD Disclosure (May 30, 2023)

Summary

Key Highlights

Frequently Asked Questions